These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3630106)

  • 1. [Effect of cholestyramine on the clinico-biochemical indices of ischemic heart disease patients].
    Serkova VK; Mikunis RI
    Vrach Delo; 1987 Jul; (7):14-7. PubMed ID: 3630106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of cholestyramine by patients with chronic ischemic heart disease].
    Vygovskiĭ VP; Proniv LN
    Vrach Delo; 1987 Feb; (2):77-9. PubMed ID: 3646817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of a high-protein diet on the effectiveness of the treatment o patients with ischemic heart disease associated with diseases of the biliary tract].
    Shchedrunov VV; Sergeev VN
    Klin Med (Mosk); 1989 May; 67(5):41-5. PubMed ID: 2770208
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood lipids and lipoproteins in patients with ischemic heart disease without hyperlipoproteinemia].
    Tokarskaia ZB; Tel'nov VI
    Ter Arkh; 1982; 54(5):43-6. PubMed ID: 7101185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of combined treatment using the drinking of sodium bicarbonate mineral water and electrosleep procedures on lipid metabolism in ischemic heart disease patients].
    Kosoverov EO
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (1):12-5. PubMed ID: 6324481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of estrogens on lipid metabolism in patients with climacteric myocardiodystrophy alone and associated with ischemic heart disease].
    Kretova NE; Neverov IV; Novikov VT; Kozlova RI; Spinova RP
    Klin Med (Mosk); 1984 Mar; 62(3):81-5. PubMed ID: 6716934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dyslipoproteinemias and the circadian variability of the lipid content of the blood in ischemic heart disease].
    Seliverstova GP; Oranskiĭ IE
    Lab Delo; 1983; (1):14-7. PubMed ID: 6185723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary prevention of coronary disease by modification of the lipids].
    Augustin J
    Dtsch Med Wochenschr; 1984 Jun; 109(24):965-7. PubMed ID: 6376043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of blood lipids and indicators of lipid peroxidation and energy metabolism after administration of Essentiale to patients with ischemic heart disease].
    Serkova VK
    Klin Med (Mosk); 1986 Jul; 64(7):91-5. PubMed ID: 3762044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of butadione on lipid metabolism in chronic ischemic heart disease patients].
    Ermalinskiĭ AF; Balakin AK; Iukhnovets RA; Vedenina RF
    Vrach Delo; 1986 Feb; (2):53-5. PubMed ID: 3085352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of nutritional correction in the prevention of ischemic heart disease].
    Smoliar VI; Davidenko NV; Smirnova IP
    Gig Sanit; 1986 Apr; (4):8-12. PubMed ID: 3710223
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the antioxidant dibunol on the composition and lipid peroxidation intensity of the blood of ischemic heart disease patients].
    Sal'nikov MI; Barsel' VA; Arkhipova GV
    Dokl Akad Nauk SSSR; 1984; 278(3):747-51. PubMed ID: 6499651
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fatty acid and adenine nucleotide content of the blood in heart failure in ischemic heart disease patients].
    Neverov IN; Novikov VT; Spinova RP; Kozlova RI; Korypaev AI
    Klin Med (Mosk); 1985 Dec; 63(12):86-9. PubMed ID: 4094396
    [No Abstract]   [Full Text] [Related]  

  • 16. [Status of the prostacyclin and thromboxane system, lipid metabolism and lipid peroxidation processes in patients with coronary atherosclerosis].
    Efimov VV; Ladnyĭ AI
    Vrach Delo; 1986 Apr; (4):37-40. PubMed ID: 3754994
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol metabolism in patients with coronary heart disease.
    Miettinen TA
    Ann Clin Res; 1971 Dec; 3(6):313-22. PubMed ID: 5156891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension].
    Pogozheva AV; Samsonov MA; Levachev MM
    Vopr Pitan; 1996; (1):34-6. PubMed ID: 9157710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
    Cisarik F; Gavalec M; Zánová J; Hrbánová Z
    Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.